急性心肌梗死质量指标达标率的性别差异:全国队列研究
基于英格兰和威尔士2003—2013年691 290例急性心肌梗死住院的全国队列,女性在16项ESC ACCA质量指标中有13项达标率低于男性,30天风险校正死亡率中位数更高,估计若达标率与男性相同可预防8243例女性死亡。
要点
- 女性AMI患者多项指南推荐治疗达标率低于男性。
- 女性30天风险校正死亡率中位数高于男性。
- 提高女性AMI指南推荐治疗达标率可能缩小性别死亡率差距。
核心结论
- 按ESC ACCA AMI质量指标,英格兰和威尔士女性指南指示治疗达标率低于男性且死亡率显著更高。
- 提高女性AMI推荐治疗实施有望缩小性别相关的AMI死亡率差距。
研究设计与样本
- 全国队列研究,纳入英格兰和威尔士233家医院2003年1月1日至2013年6月30日691 290例AMI住院。
- 女性238 489例(34.5%),中位年龄76.7岁(IQR 66.3-84.0),STEMI占33.9%(80 884例)。
- 男性452 801例(65.5%),中位年龄67.1岁(IQR 56.9-77.2),STEMI占42.5%(192 229例)。
主要发现
- 女性在16项质量指标中有13项接受率低于男性。
- STEMI及时再灌注治疗女性76.8% vs 男性78.9%(p<0.001)。
- 非STEMI及时冠状动脉造影女性24.2% vs 男性36.7%(p<0.001)。
- 双联抗血小板治疗女性75.4% vs 男性78.7%;他汀87.2% vs 89.6%、ACEI/ARB 82.5% vs 85.6%、β受体阻滞剂62.6% vs 67.6%(均p<0.001)。
- 30天GRACE风险评分校正死亡率中位数女性5.2%(IQR 1.8%-13.1%)vs 男性2.3%(IQR 0.8%-7.1%),p<0.001;若达标率等同男性,研究期间估计可预防8243例女性死亡(95%CI 8111-8375)。
临床怎么用
- 对女性AMI患者应重点关注指南推荐治疗(再灌注、冠脉造影、双联抗血小板及二级预防)的落实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate sex differences in acute myocardial infarction (AMI) guideline-indicated care as defined by the European Society of Cardiology (ESC) Acute Cardiovascular Care Association (ACCA) quality indicators. METHODS: Nationwide cohort study comprising 691 290 AMI hospitalisations in England and Wales (n=233 hospitals) from the Myocardial Ischaemia National Audit Project between 1 January 2003 and 30 June 2013. RESULTS: There were 34.5% (n=238 489) women (median age 76.7 (IQR 66.3-84.0) years; 33.9% (n=80 884) ST-elevation myocardial infarction (STEMI)) and 65.5% (n=452 801) men (median age 67.1 (IQR 56.9-77.2) years; 42.5% (n=192 229) STEMI). Women less frequently received 13 of the 16 quality indicators compared with men, including timely reperfusion therapy for STEMI (76.8% vs 78.9%; p<0.001), timely coronary angiography for non-STEMI (24.2% vs 36.7%; p<0.001), dual antiplatelet therapy (75.4% vs 78.7%) and secondary prevention therapies (87.2% vs 89.6% for statins, 82.5% vs 85.6% for ACE inhibitor/angiotensin receptor blockers and 62.6% vs 67.6% for beta-blockers; all p<0.001). Median 30-day Global Registry of Acute Coronary Events risk score adjusted mortality was higher for women than men (median: 5.2% (IQR 1.8%-13.1%) vs 2.3% (IQR 0.8%-7.1%), p<0.001). An estimated 8243 (95% CI 8111 to 8375) deaths among women could have been prevented over the study period if their quality indicator attainment had been equal to that attained by men. CONCLUSION: According to the ESC ACCA AMI quality indicators, women in England and Wales less frequently received guideline-indicated care and had significantly higher mortality than men. Greater attention to the delivery of recommended AMI treatments for women has the potential to reduce the sex-AMI mortality gap.
引用
- Wilkinson C, Bebb O, Dondo TB, et al. Sex differences in quality indicator attainment for myocardial infarction: a nationwide cohort study. Heart. 2018. PMID: 30470725. doi:10.1136/heartjnl-2018-313959
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。